Tuberculosis

R-Biopharm launches new generation of tuberculosis diagnostics with IP-10. This represents a major leap forward from traditional interferon-gamma release assays. The diagnostic is based on [...]

Ready to embrace the future of T-cell based tuberculosis diagnosis? Three tubes, two choices – Rapid Test or ELISA: Complete the form below, and our team will reach out with more [...]

Darmstadt, Germany, June 27, 2018 – R-Biopharm Group announced today a collaborative agreement with Statens Serum Institute (SSI, Denmark), focusing on discovery and development of novel [...]